ABBV stock · HYPD stock

ABBV vs HYPD · P/E 81, rev $61.16B vs rev $57.3K

AbbVie Inc (ABBV) versus Hyperion DeFi, Inc. (HYPD) — a side-by-side from cached financials, not a winner call.

AbbVie Inc (ABBV) is a drug manufacturers - general company listed on US. It is led by Rob Michael.

Hyperion DeFi, Inc. (HYPD) is a biotechnology company listed on NASDAQ.

Latest reported ABBV revenue for 2025-12-31 was $61.16B. Net income was $4.23B. Revenue was up 305.0% from 2024-12-31 to 2025-12-31. ABBV currently screens at market cap $334.34B and trailing P/E 80.5.

Latest reported HYPD revenue for 2024-12-31 was $57.3K. Net income was -$49.8M. Revenue was up 1414.0% from 2023-12-31 to 2024-12-31. HYPD currently screens at market cap $48.5M.

ABBV currently screens at market cap $334.34B and trailing P/E 80.5. HYPD currently screens at market cap $48.5M.

Not investment advice. Open the ABBV and HYPD stock pages for the full models.

Not investment advice.

Popular Stock Comparisons